Skip to main content
BEIJING AOSAIKANG PHARMACEUTICAL CO.,LTD logo

BEIJING AOSAIKANG PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002755 ISIN · CNE100001X92 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,261 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002755

About BEIJING AOSAIKANG PHARMACEUTICAL CO.,LTD

https://www.ask-pharm.com

Beijing Aosaikang Pharmaceutical Co., Ltd. is a research-driven pharmaceutical enterprise specializing in the development, manufacture, and commercialization of innovative drugs and high-end generic medications. The company maintains a significant focus on therapeutic areas including oncology, gastroenterology, anti-infectives, and cardiovascular health. It is recognized for its expertise in injectable formulations, particularly proton pump inhibitors and anti-tumor agents. Aosaikang operates integrated R&D platforms and modern production facilities designed to meet international quality standards. By prioritizing clinical needs and technological innovation, the company aims to provide effective treatment solutions for complex diseases, establishing a strong presence in both domestic and international healthcare markets.

Recent filings

Filing Released Lang Actions
国浩律师（南京）事务所关于北京奥赛康药业股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 45% confidence The document is a formal legal opinion letter (“法律意见书”) from a law firm on the legality and validity of Beijing Osaikon Pharmaceutical’s 2025 Annual General Shareholders’ Meeting, detailing procedures, attendee qualifications, and vote tallies. It is not itself an AGM presentation (AGM-R), proxy materials (PSI), or the company’s own voting results notice (DVA)—instead, it is a compliance/legal document authored by external counsel. It does not contain financial statements, call transcripts, or capital updates, nor is it part of an ongoing litigation report (LTR). As a bespoke legal compliance filing, it falls under the “Regulatory Filings” catch-all category (RNS).
2026-05-29 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is a formal announcement by the company’s board detailing the resolutions passed at its 2025 Annual General Meeting, including vote counts for each agenda item. This corresponds exactly to a “Declaration of Voting Results & Voting Rights Announcement” rather than an AGM presentation, financial report, or other filing type.
2026-05-29 Chinese
投资者关系管理制度（2025年）
Governance Information Classification · 95% confidence The document is titled '投资者关系管理制度' which translates to 'Investor Relations Management System'. It details the company's policies, principles, organizational structure, and procedures for managing investor relations, including communication with investors, information disclosure, and compliance with relevant laws and regulations. It does not contain financial statements, earnings data, voting results, or any specific report content. Instead, it is a governance-related document outlining internal rules and practices related to investor relations and corporate governance. Therefore, it fits best under the category of Governance Information (CGR). The document length is sufficient and it is not an announcement or a brief notice, but a detailed governance policy document.
2025-08-28 Chinese
董事会提名委员会议事规则（2025年）
Governance Information Classification · 95% confidence The document is titled as the 'Rules of Procedure for the Nomination Committee of the Board of Directors' of Beijing Aosai Kang Pharmaceutical Co., Ltd. It details the composition, responsibilities, decision-making procedures, and meeting rules of the nomination committee within the board. There is no financial data, no mention of financial results, no regulatory filings or announcements of voting results, no legal proceedings, no capital changes, no earnings information, and no investor presentations. The content is focused on governance structure and internal rules related to board nominations and management appointments. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 2272 characters, which is sufficient for a detailed governance document and not a brief announcement. Therefore, the classification is CGR with high confidence.
2025-08-28 Chinese
公司章程（2025年）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Beijing Aosaikang Pharmaceutical Co., Ltd., dated August 2025. It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, share issuance, share transfer, shareholder meetings, and other governance matters. It is a comprehensive governance document outlining the internal rules and regulations of the company rather than a financial report, announcement, or meeting minutes. There is no indication that this is an annual report, audit report, earnings release, or any other financial or regulatory filing. The content matches the description of Governance Information, which covers the company's internal rules, board structure, and governance practices.
2025-08-28 Chinese
2025年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "北京奥赛康药业股份有限公司2025年半年度财务报告" which translates to "Beijing Aosai Kang Pharmaceutical Co., Ltd. 2025 Semi-Annual Financial Report." It contains detailed financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2025. The document explicitly states it is a half-year financial report and includes comprehensive financial data and analysis for the period. It is not an announcement or a brief summary but a full financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-28 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.